246 related articles for article (PubMed ID: 10364311)
1. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.
Zavorotinskaya T; Albritton LM
J Virol; 1999 Jul; 73(7):5621-9. PubMed ID: 10364311
[TBL] [Abstract][Full Text] [Related]
2. The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex.
Li Z; Pinter A; Kayman SC
J Virol; 1997 Sep; 71(9):7012-9. PubMed ID: 9261431
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus.
Felkner RH; Roth MJ
J Virol; 1992 Jul; 66(7):4258-64. PubMed ID: 1318404
[TBL] [Abstract][Full Text] [Related]
4. A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor.
Zavorotinskaya T; Albritton LM
J Virol; 1999 Dec; 73(12):10164-72. PubMed ID: 10559332
[TBL] [Abstract][Full Text] [Related]
5. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
[TBL] [Abstract][Full Text] [Related]
6. Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes.
Lebedeva I; Fujita K; Nihrane A; Silver J
J Virol; 1997 Sep; 71(9):7061-7. PubMed ID: 9261436
[TBL] [Abstract][Full Text] [Related]
7. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation.
Dubay JW; Dubay SR; Shin HJ; Hunter E
J Virol; 1995 Aug; 69(8):4675-82. PubMed ID: 7609032
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
[TBL] [Abstract][Full Text] [Related]
10. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry.
Ragheb JA; Anderson WF
J Virol; 1994 May; 68(5):3220-31. PubMed ID: 8151784
[TBL] [Abstract][Full Text] [Related]
11. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain.
Taylor GM; Sanders DA
Virology; 2003 Aug; 312(2):295-305. PubMed ID: 12919735
[TBL] [Abstract][Full Text] [Related]
12. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
13. The central proline of an internal viral fusion peptide serves two important roles.
Delos SE; Gilbert JM; White JM
J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
[TBL] [Abstract][Full Text] [Related]
14. Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.
Ikeda H; Kato K; Suzuki T; Kitani H; Matsubara Y; Takase-Yoden S; Watanabe R; Kitagawa M; Aizawa S
J Virol; 2000 Feb; 74(4):1815-26. PubMed ID: 10644355
[TBL] [Abstract][Full Text] [Related]
15. Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.
Battini JL; Danos O; Heard JM
J Virol; 1998 Jan; 72(1):428-35. PubMed ID: 9420242
[TBL] [Abstract][Full Text] [Related]
16. Mutational library analysis of selected amino acids in the receptor binding domain of envelope of Akv murine leukemia virus by conditionally replication competent bicistronic vectors.
Bahrami S; Jespersen T; Pedersen FS; Duch M
Gene; 2003 Oct; 315():51-61. PubMed ID: 14557064
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
18. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.
Denesvre C; Carrington C; Corbin A; Takeuchi Y; Cosset FL; Schulz T; Sitbon M; Sonigo P
J Virol; 1996 Jul; 70(7):4380-6. PubMed ID: 8676461
[TBL] [Abstract][Full Text] [Related]
19. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry.
Ragheb JA; Anderson WF
J Virol; 1994 May; 68(5):3207-19. PubMed ID: 7512161
[TBL] [Abstract][Full Text] [Related]
20. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
